Narrowing prices and growing product lines have brought both legal retailers and regulators face to face with Canada's flowering illicit cannabis market.

Since its inception in 2018, the Cannabis Act has guided Canada's cannabis market through its share of highs and lows. At the five-year mark, one challenge has emerged as a top priority: the rise of illicit markets. These unregulated vendors—with their diverse products and attractive pricing—are drawing consumers in.

How cannabis pricing differs from other consumer goods

Since its legalization in Canada, cannabis production and retail has blossomed from a seedling industry into one of North America’s most rapidly developing markets. As the industry grows toward full maturity, we decided to look at how pricing in the market has evolved.

2021 cannabis consumer report

As Canada enters its third year of legalized recreational cannabis use, what’s next for the industry?

2020 cannabis report

How can cannabis companies change course, evolve, and mature in global markets? Read our 2020 report to discover how to harness growth and move forward with confidence.

Cannabis biosynthesis technology offers many important advantages for life sciences companies and licensed producers (LPs) including cost-effectiveness and better opportunity for quality. Explore how this technology can change the competitive landscape for life sciences companies and LPs.

Canada gets ready for cannabis 2.0

All eyes remain on Canada as it prepares for the next stage of cannabis legalization—a step that will keep the country firmly at the vanguard of a societal revolution and a new industry exploding with potential.